BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Nosology, Rapamycin, rs2230926, NEUROG3, Coagulation, HIV infection, Intestine)
Bookmark Forward

QuickView for b7 antigens (compound)


Genetic Markers

Most Correlated Genes

  1. GZMB
  2. ADM2
  3. CXCL8
  4. LINC-PINT
  5. EGR1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. BERENJENO_TRANSFORMED_BY_RHOA_UP
  2. PUJANA_BRCA1_PCC_NETWORK
  3. PUJANA_CHEK2_PCC_NETWORK
  4. DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
  5. FISCHER_DREAM_TARGETS
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Response to IL-12 and Type I IFN with or without TCR and CD28 T-lymphocyte stimulation
  2. CD8+ T cells from OT-1 mice after exposure to PD-L1
  3. Colorectal cancer (HT29 & HCT116) and melanoma PES43 cells treated with Nivolumab, sPD-L1 or both
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response fo…
  2. Analysis of the different subpeptidomes presented by the HLA class I molecules of the B7 supertype.
  3. Kinetic Changes in B7 Costimulatory Molecules and IRF4 Expression in Human Dendritic Cells during LP…
  4. ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against …
  5. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns cor…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
  2. B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme
  3. TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
  4. Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
  5. Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.